We aim to fuel breakthroughs in healthcare by investing in visionary technology-driven startups, and providing them with the support and resources they need to succeed.
Our mission is to identify and invest in early-stage biotech and medtech startups with the potential to revolutionize healthcare and to support these companies with the resources and guidance they need to bring their innovations to market and improve patient condition.
The Fund has closed its investment portfolio and is currently focused on supporting startups and seeking business partners.
Solutions for reducing healthcare costs, innovations in preventive healthcare, innovations in elderly support.
Medical devices, diagnostic tests, medical software, technology-based solutions that are used to prevent, diagnose, and treat medical conditions.
Innovative medicines and therapies, biomaterials
SynexCare
Miniaturized Holter recorder coupled with AI-enabled multifunctional cloud platform for data management and analysis
Klub Aktywnych
Klub Aktywnych is a platform dedicated to women 55+ designed for online/live meetings and trainings.
Hi Orthotics
Innovative and miniaturized intelligent knee braces to support patients with lower limb dysfunctions
Alreh Care
Modern and innovative dynamic standers and safety platforms equipped with AR-gaming capabilities for active rehabilitation
Opti G
The Opti-G guidewire is a diagnostic device that allows precise diagnosis of the nature of the coronary occlusion
Virtual Monitor
Virtual Monitor is a platform that simplifies clinical trials by enabling remote and paperless trials, reducing costs, and time spent on individual activities for Sponsors, CROs, and Investigators.
Ideal Bistro Healthcare
Employee meal management system in the workplace zone – an organized process of ordering, distributing, and collecting meals, with a unique computer system integrated with Foodomat-type devices located near the employee
DEMOX Lab
Quick and non-invasive diagnostic test for an eye parasite – Demodex Spp. mite causing chronic inflammation of the eyelid margin.
Mycogress by Mycocycle
Mycelium-fueled waste management, Mycoremediation and Mycocosmentics. Mycogress develops a natural cosmetic material using selected mycelium strains and apple waste for mask and cosmetic base production, advancing eco-friendly waste solutions with Mycocycle Inc.
Target Cells by TargaCell
In-vitro stem cell binding assay. Target Cells sp. z o.o. (PL) is collaborating with TargaCell Inc. (USA) to create a test that evaluates the capability of different fractions of human stem cells to adhere to the endothelium of heart tissues in vitro.
CannabIBS by Greenspace Labs Inc
Innovative OTC drug for the treatment of irritable bowel syndrome (IBS). CannabIBS sp. z o.o. (PL) in cooperation with Greenspace Labs Inc. (USA) is conducting a pilot clinical trial to prove safety and efficacy of novel non-psychoactive cannabinoid-based treatment for IBS
Piotr Wiliński, PhD
CEOTechnology and innovation executive, manager of businesses in international corporations and high-tech startups, author of 30+ patents
Suzanne Reade
Venture PartnerPolish-American corporate manager in financial services companies, president and founder of the Chicago ArchAngels
Marek Kowalczyk
Venture parnterBusiness entrepreneur with over 20 years of experience in identifying business opportunities, launching and leading successful companies (founder and CEO of IDEA Furniture, Co. a Chicago based furniture retail & import Company)
Andrzej Koziarski
Venture partnerPolish-American business professional in food retail industry (founder and CEO Marketplace Brands and Old World Quality Foods) with financial and entrepreneurship background with over 20 years of experience
Andrzej Kraszewski
Investment manager, analystAlumni of Inter-faculty Individual Studies in Mathematics and Natural Sciences, chemist and molecular biologist
